Next-Generation Sequencing
The latest news on next-generation sequencing.
Industry insiders said Resolution Bio may be a better fit under Exact Sciences and think it could augment Exact's cancer testing portfolio.
Agilent Technologies Selling Resolution Bioscience to Exact Sciences
The firms announced a deal, for an undisclosed sum, about one month after Agilent announced plans to shutter the Resolution Bioscience business.
The firm is offering its epiCervix assay in the US as a laboratory-developed test to be used alongside human papillomavirus screening.
Geneseeq Nabs CE Marks for Cancer Test Kits
The Toronto-based firm gained marketing clearance in Europe for two kits for profiling solid tumors and one kit for hematological cancer genomic profiling.
For Q3, the firm said its diagnostics revenues rose 3 percent, but Resolution's kitted NGS-based companion diagnostics business hadn't developed as expected.